Skip to main
EIGR
EIGR logo

Eiger BioPharmaceuticals (EIGR)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Eiger BioPharmaceuticals (EIGR) Stock

About Eiger BioPharmaceuticals (EIGR)

Eiger BioPharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development of innovative therapies for rare metabolic diseases. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia. The company was founded by David A. Cory and Glenn S. Jeffrey on November 6, 2008 and is headquartered in Palo Alto, CA.
Market cap$12.59M
Today's volume
Revenue (TTM)
Avg. daily volume9.34K
EBITDA (TTM)
Open
Price / earnings ratio-0.17x
Today's range
Debt / equity
52 week range$1.1 - $16
5 year debt / equity38.97x
Beta (LTM)1.16x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 9, 2023
Dividend payable date

Eiger BioPharmaceuticals Stock Rating

What analysts recommend for EIGR stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 26, 2025, the market cap for EIGR stock is $12.59M

The current P/E ratio for EIGR stock is -0.17

The 52-week high for EIGR stock is $16. The current EIGR stock price $undefined is 100.00% below its 52-week high

The 52-week low for EIGR stock is $1.10. The current EIGR stock price $undefined has increased 100.00% from its 52-week low

No, the EIGR stock does not pay dividends to its shareholders

The target price for EIGR stock is $27.56 based on the average of what a group of analyst think EIGR stock could be worth at a future date. This is not a prediction by Public.com

How to buy EIGR stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in EIGR stock

    Navigate to the Explore page. Then, type EIGR into the search bar. When you see EIGR stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased EIGR stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Eiger BioPharmaceuticals Stock Earnings

The value each EIGR share was expected to gain vs. the value that each EIGR share actually gained.

Eiger BioPharmaceuticals (EIGR) reported Q3 2023 earnings per share (EPS) of -$12.30, missing estimates of -$9.60 by 28.13%. In the same quarter last year, Eiger BioPharmaceuticals's earnings per share (EPS) was -$18.60. Eiger BioPharmaceuticals is expected to release next earnings on 11/09/2023, with an earnings per share (EPS) estimate of $0.

Buy Eiger BioPharmaceuticals (EIGR) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.